Skip to main content
. Author manuscript; available in PMC: 2015 Sep 1.
Published in final edited form as: Lung Cancer. 2014 Jun 27;85(3):449–456. doi: 10.1016/j.lungcan.2014.06.014

Table 2.

Selected crude and adjusted hazard ratio of PPAR SNPs and lung cancer survival, stratified by morphological types*.

PPARD rs3734254 T>C
PPARG rs10865710 C>G
Genotype Death/All cHR (95% CI) aHR** (95% CI) Posterior aHR** (95% posterior limits) Genotype Death/All cHR (95% CI) aHR** (95% CI) Posterior aHR** (95% posterior limits)
Lung Cancer (N=611)
TT 193/289 1.00 1.00 1.00 CC 186/286 1.00 1.00 1.00
TC 112/168 1.02(0.81, 1.29) 1.07(0.83, 1.37) 1.08(0.84, 1.37) CG 130/192 1.11(0.88, 1.38) 1.06(0.84, 1.34) 1.06(0.85, 1.33)
CC 29/55 0.65(0.44, 0.96) 0.63(0.42, 0.96) 0.66(0.44, 0.98) GG 24/39 0.99(0.65, 1.51) 1.11(0.71, 1.73) 1.10(0.72, 1.68)
Ptrend 0.10 0.15 0.16 Ptrend 0.62 0.54 0.54
Recessive 29/55 0.64(0.44, 0.94) 0.61(0.41, 0.92) 0.64(0.43, 0.94) Recessive 24/39 0.95(0.63, 1.44) 1.07(0.70, 1.66) 1.07(0.71, 1.62)
Non-SCLC (N=536)
TT 162/251 1.00 1.00 1.00 CC 162/254 1.00 1.00 1.00
TC 97/150 1.04(0.81, 1.34) 1.04(0.80, 1.36) 1.05(0.80, 1.36) CG 105/162 1.05(0.82, 1.34) 1.03(0.80, 1.33) 1.03(0.80, 1.32)
CC 24/46 0.69(0.45, 1.06) 0.69(0.44, 1.09) 0.72(0.47, 1.10) GG 22/36 1.00(0.64, 1.55) 1.14(0.71, 1.33) 1.12(0.72, 1.76)
Ptrend 0.24 0.28 0.28 Ptrend 0.83 0.63 0.63
Recessive 24/46 0.68(0.45, 1.03) 0.68(0.44, 1.05) 0.70(0.47, 1.06) Recessive 22/36 0.98(0.63, 1.51) 1.12(0.71, 1.78) 1.11(0.72, 1.72)
SQC (N=95)
TT 23/43 1.00 1.00 1.00 CC 18/35 1.00 1.00 1.00
TC 16/27 1.22(0.65, 2.32) 1.51(0.74, 3.05) 1.40(0.75, 2.60) CG 22/37 1.27(0.68, 2.37) 1.35(0.68, 2.67) 1.26(0.69, 2.29)
CC 5/10 0.94(0.36, 2.46) 0.91(0.30, 2.71) 0.92(0.39, 2.13) GG 4/8 0.95(0.32, 2.80) 1.21(0.35, 4.19) 1.09(0.43, 2.75)
Ptrend 0.87 0.75 0.77 Ptrend 0.76 0.50 0.53
Recessive 5/10 0.86(0.34, 2.20) 0.74(0.26, 2.09) 0.82(0.36, 1.86) Recessive 4/8 0.84(0.30, 2.34) 1.01(0.31, 3.27) 1.01(0.41, 2.47)
ABC (N=297)
TT 82/137 1.00 1.00 1.00 CC 83/141 1.00 1.00 1.00
TC 54/87 1.13(0.80, 1.60) 1.19(0.82, 1.73) 1.18(0.83, 1.68) CG 57.89 1.22(0.87, 1.71) 1.11(0.77, 1.58) 1.09(0.78, 1.54)
CC 13/23 0.88(0.49, 1.58) 0.99(0.51, 1.92) 0.99(0.55, 1.79) GG 13/20 1.37(0.76, 2.46) 1.24(0.65, 2.33) 1.19(0.66, 2.12)
Ptrend 0.97 0.64 0.64 Ptrend 0.16 0.45 0.46
Recessive 13/23 0.84(0.48, 1.49) 0.90(0.48, 1.69) 0.92(0.52, 1.63) Recessive 13/20 1.27(0.72, 2.24) 1.18(0.64, 2.17) 1.15(0.65, 2.02)
LCC (N=115)
TT 45/56 1.00 1.00 1.00 CC 50/64 1.00 1.00 1.00
TC 23/31 0.82(0.50, 1.35) 0.68(0.37, 1.25) 0.75(0.44, 1.30) CG 19/27 0.74(0.44, 1.26) 0.85(0.48, 1.48) 0.87(0.52, 1.45)
CC 4/9 0.34(0.12, 0.95) 0.32(0.09, 1.06) 0.50(0.22, 1.15) GG 4/7 0.55(0.20, 1.52) 0.87(0.26, 2.92) 0.93(0.38, 2.29)
Ptrend 0.04 0.03 0.04 Ptrend 0.14 0.59 0.61
Recessive 4/9 0.37(0.13, 1.01) 0.36(0.11, 1.20) 0.54(0.24, 1.23) Recessive 4/7 0.60(0.22, 1.65) 0.94(0.28, 3.07) 0.96(0.39, 2.36)
SCLC (N=75)
TT 31/38 1.00 1.00 1.00 CC 24/32 1.00 1.00 1.00
TC 15/18 1.04(0.56, 1.92) 1.22(0.61, 2.45) 1.19(0.64, 2.22) CG 25/30 1.28(0.73, 2.25) 1.03(0.54, 1.95) 1.03(0.58, 1.84)
CC 5/9 0.43(0.17, 1.10) 0.67 (0.20, 2.18) 0.78(0.32, 1.91) GG 2/3 1.17(0.28, 4.93) 0.80(0.17, 3.69) 0.90(0.33, 2.46)
Ptrend 0.13 0.84 0.85 Ptrend 0.45 0.91 0.92
Recessive 5/9 0.42(0.17, 1.07) 0.63(0.20, 2.03) 0.76(0.32, 1.84) Recessive 2/3 1.04(0.25, 4.27) 0.79(0.18, 3.43) 0.89(0.33, 2.39)
*

Due to many 0 counts of PPARG rs1801282, the corresponding results were presented in supplementary tables.

**

Adjusted by age, gender, ethnicity, education level, smoking as packyears and tumor cell differentiation and morphology including squamous carcinoma, adenocarcinoma and large cell carcinoma and small cell carcinoma, if applicable.